Haemochromatosis
- PMID: 37121243
- DOI: 10.1016/S0140-6736(23)00287-8
Haemochromatosis
Abstract
Haemochromatosis is one of the most common genetic diseases affecting patients of northern European ancestry. It is overdiagnosed in patients without iron overload and is underdiagnosed in many patients. Early diagnosis by genetic testing and therapy by periodic phlebotomy can prevent the most serious complications, which include liver cirrhosis, liver cancer, and death. This Seminar includes an update on the origins of haemochromatosis; and an overview pathophysiology, genetics, natural history, signs and symptoms, differential diagnoses, treatment with phlebotomy, outcomes, and future directions.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests PCA has been an advisor to Sanofi and Imara. JR has consulted for Bond Biosciences, Pfizer, Gilead, Kyowa Kirin, and Falk. GJ declares no competing interests.
Comment in
-
Concerns about new proposals for haemochromatosis screening.Lancet. 2023 Aug 26;402(10403):690-691. doi: 10.1016/S0140-6736(23)01506-4. Lancet. 2023. PMID: 37633663 No abstract available.
-
Concerns about new proposals for haemochromatosis screening.Lancet. 2023 Aug 26;402(10403):691-692. doi: 10.1016/S0140-6736(23)01507-6. Lancet. 2023. PMID: 37633664 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
